Literature DB >> 27193397

Peptide-based systems analysis of inflammation induced myeloid-derived suppressor cells reveals diverse signaling pathways.

Waeowalee Choksawangkarn1,2, Lauren M Graham1, Meghan Burke1, Sang Bok Lee1,3, Suzanne Ostrand-Rosenberg4, Catherine Fenselau1, Nathan J Edwards5.   

Abstract

A better understanding of molecular signaling between myeloid-derived suppressor cells (MDSC), tumor cells, T-cells, and inflammatory mediators is expected to contribute to more effective cancer immunotherapies. We focus on plasma membrane associated proteins, which are critical in signaling and intercellular communication, and investigate changes in their abundance in MDSC of tumor-bearing mice subject to heightened versus basal inflammatory conditions. Using spectral counting, we observed statistically significant differential abundances for 35 proteins associated with the plasma membrane, most notably the pro-inflammatory proteins S100A8 and S100A9 which induce MDSC and promote their migration. We also tested whether the peptides associated with canonical pathways showed a statistically significant increase or decrease subject to heightened versus basal inflammatory conditions. Collectively, these studies used bottom-up proteomic analysis to identify plasma membrane associated pro-inflammatory molecules and pathways that drive MDSC accumulation, migration, and suppressive potency.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Cell migration; Differential protein expression; Immune suppression; Inflammation; Mass spectrometry - LC-MS/MS; Myeloid-derived suppressor cells; Systems biology

Mesh:

Substances:

Year:  2016        PMID: 27193397      PMCID: PMC6174082          DOI: 10.1002/pmic.201500102

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  35 in total

1.  Profiling of the cell surface proteome.

Authors:  Jun Ho Jang; Samir Hanash
Journal:  Proteomics       Date:  2003-10       Impact factor: 3.984

2.  CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice.

Authors:  Lydia A Haile; Jaba Gamrekelashvili; Michael P Manns; Firouzeh Korangy; Tim F Greten
Journal:  J Immunol       Date:  2010-06-04       Impact factor: 5.422

3.  A method for the quantitative recovery of protein in dilute solution in the presence of detergents and lipids.

Authors:  D Wessel; U I Flügge
Journal:  Anal Biochem       Date:  1984-04       Impact factor: 3.365

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 5.  Inflammation, a key event in cancer development.

Authors:  Haitian Lu; Weiming Ouyang; Chuanshu Huang
Journal:  Mol Cancer Res       Date:  2006-04       Impact factor: 5.852

Review 6.  Myeloid-derived suppressor cells: linking inflammation and cancer.

Authors:  Suzanne Ostrand-Rosenberg; Pratima Sinha
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

7.  Synthesis of superparamagnetic nanotubes as MRI contrast agents and for cell labeling.

Authors:  Xia Bai; Sang Jun Son; Shixiong Zhang; Wei Liu; Elaine K Jordan; Joseph A Frank; Thirumalai Venkatesan; Sang Bok Lee
Journal:  Nanomedicine (Lond)       Date:  2008-04       Impact factor: 5.307

8.  Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein.

Authors:  Pingyan Cheng; Cesar A Corzo; Noreen Luetteke; Bin Yu; Srinivas Nagaraj; Marylin M Bui; Myrna Ortiz; Wolfgang Nacken; Clemens Sorg; Thomas Vogl; Johannes Roth; Dmitry I Gabrilovich
Journal:  J Exp Med       Date:  2008-09-22       Impact factor: 14.307

9.  The GOA database: gene Ontology annotation updates for 2015.

Authors:  Rachael P Huntley; Tony Sawford; Prudence Mutowo-Meullenet; Aleksandra Shypitsyna; Carlos Bonilla; Maria J Martin; Claire O'Donovan
Journal:  Nucleic Acids Res       Date:  2014-11-06       Impact factor: 19.160

10.  Modulation of the antitumor immune response by complement.

Authors:  Maciej M Markiewski; Robert A DeAngelis; Fabian Benencia; Salome K Ricklin-Lichtsteiner; Anna Koutoulaki; Craig Gerard; George Coukos; John D Lambris
Journal:  Nat Immunol       Date:  2008-09-28       Impact factor: 25.606

View more
  11 in total

1.  Differential Content of Proteins, mRNAs, and miRNAs Suggests that MDSC and Their Exosomes May Mediate Distinct Immune Suppressive Functions.

Authors:  Lucía Geis-Asteggiante; Ashton T Belew; Virginia K Clements; Nathan J Edwards; Suzanne Ostrand-Rosenberg; Najib M El-Sayed; Catherine Fenselau
Journal:  J Proteome Res       Date:  2017-11-27       Impact factor: 4.466

Review 2.  Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.

Authors:  Suzanne Ostrand-Rosenberg; Catherine Fenselau
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

3.  S100A8/A9 Drives Neuroinflammatory Priming and Protects against Anxiety-like Behavior after Sepsis.

Authors:  Scott J Denstaedt; Joanna L Spencer-Segal; Michael W Newstead; Klaudia Laborc; Anne P Zhao; Alexander Hjelmaas; Xianying Zeng; Huda Akil; Theodore J Standiford; Benjamin H Singer
Journal:  J Immunol       Date:  2018-03-21       Impact factor: 5.422

4.  Ubiquitin Conjugation Probed by Inflammation in Myeloid-Derived Suppressor Cell Extracellular Vesicles.

Authors:  Katherine R Adams; Sitara Chauhan; Divya B Patel; Virginia K Clements; Yan Wang; Steven M Jay; Nathan J Edwards; Suzanne Ostrand-Rosenberg; Catherine Fenselau
Journal:  J Proteome Res       Date:  2017-11-10       Impact factor: 4.466

5.  Application of Higher Density Iron Oxide Nanoparticle Pellicles to Enrich the Plasma Membrane and Its Proteome from Cells in Suspension.

Authors:  Rebecca L Rose; Waeowalee Choksawangkarn; Catherine Fenselau
Journal:  Methods Mol Biol       Date:  2018

Review 6.  Myeloid-Derived Suppressor Cells.

Authors:  Dmitry I Gabrilovich
Journal:  Cancer Immunol Res       Date:  2017-01       Impact factor: 11.151

Review 7.  Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy.

Authors:  Shweta Joshi; Andrew Sharabi
Journal:  Pharmacol Ther       Date:  2022-02-02       Impact factor: 13.400

Review 8.  Molecular cargo in myeloid-derived suppressor cells and their exosomes.

Authors:  Catherine Fenselau; Suzanne Ostrand-Rosenberg
Journal:  Cell Immunol       Date:  2020-12-07       Impact factor: 4.868

9.  Prospect of using deep learning for predicting differentiation of myeloid progenitor cells after sepsis.

Authors:  Wei-Shuyi Ruan; Jia Xu; Yuan-Qiang Lu
Journal:  Chin Med J (Engl)       Date:  2019-08-05       Impact factor: 2.628

10.  Prognostic Role of Monocytic Myeloid-Derived Suppressor Cells in Advanced Non-Small-Cell Lung Cancer: Relation to Different Hematologic Indices.

Authors:  Asmaa M Zahran; Helal F Hetta; Zeinab Albadry M Zahran; Alaa Rashad; Amal Rayan; Dalia O Mohamed; Zeinab Ahmed Abd Elhameed; Salah M Khallaf; Gaber El-Saber Batiha; Yasir Waheed; Khalid Muhammad; Hanaa Nafady-Hego
Journal:  J Immunol Res       Date:  2021-10-11       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.